We showed that galectin-3 expressed on the surface of colon and breast cancer cells interacted with platelet-specific receptor GPVI and this receptor-ligand mediated cellular crosstalk could enhance platelet activation and degranulation (ATP secretion) which further support tumor cell extravasation (142). This evidence concerns the gene GP6 and breast carcinoma.